Sensitivity of tumor models to immunotherapy is also associated with the tumor location, probably due to the orthotopic microenvironment, in which tumors exhibited a low response to immune checkpoint blockades (both PD1 and CTLA4 blockade). This evidence concerns the gene CTLA4 and neoplasm.